Locoregional Combined With Systemic Therapies for Advanced Hepatocellular Carcinoma: An Inevitable Trend of Rapid Development

Despite the application of antiviral drugs and improved surveillance tools, the number of patients diagnosed with hepatocellular carcinoma (HCC) at an advanced stage and with a dismal prognosis is still on the rise. Systemic treatment with multiple multitargeted tyrosine kinase inhibitors (TKIs), su...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Wang, Yaxi, Ye, Xin, Liang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076864/
https://www.ncbi.nlm.nih.gov/pubmed/33928118
http://dx.doi.org/10.3389/fmolb.2021.635243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076864/
https://www.ncbi.nlm.nih.gov/pubmed/33928118
http://dx.doi.org/10.3389/fmolb.2021.635243

Ejemplares similares